Scroll To Top
Search by Speciality

22ND ANNUAL INTERNATIONAL CONGRESS ON HEMATOLOGIC MALIGNANCIES®: FOCUS ON LEUKEMIAS, LYMPHOMAS & MYELOMA

The Diplomat Hotel | Florida, USA
From 299 to 799 USD
Event Preview
133
Days Left
For the
Event
Title: 22ND ANNUAL INTERNATIONAL CONGRESS ON HEMATOLOGIC MALIGNANCIES®: FOCUS ON LEUKEMIAS, LYMPHOMAS & MYELOMA
Specialty: Hematology and Hemotherapy
Dates: From Mar, 2, 2018 to Mar, 4, 2018
Location: Florida, USA
Type: Congress
Registration Cost: From 299 to 799 USD
Event Tools
  • Add to Favorites
  • Notify me by email
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Mar
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for FLORIDA, Usa.
General Info
Event Venue:

The Diplomat Hotel

FLORIDA, USA Visit the Venue to read more
Currency:
USD
Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

Now in its 22nd year, the annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma facilitates clinicians’ skills to contextualize the wealth of emerging data on how to treat hematologic malignancies, personalize treatment based upon patient and tumor characteristics, and apply novel management strategies to their practices to improve outcomes for their patients.


Back by popular demand! The 3-day meeting will once again be held from Friday through mid afternoon Sunday. As always, agenda topics will focus on methods to practically apply state-of-the-art strategies to your clinical practice settings. This engaging and highly interactive meeting will provide ample opportunity to interact with renowned experts in the management of leukemias, lymphomas, myeloma, myelodysplastic syndromes, myeloproliferative neoplasms, and benign hematologic malignancies. Our faculty will distill practice-changing evidence and recommend methods to place this information in its proper context and apply it to real-world care scenarios you encounter. In doing so, a focus will be placed on how to proactively mitigate and manage treatment-related toxicities associated with new treatment strategies.


The well-known and highly interactive Medical Crossfire® discussion panels interspersed throughout the meeting will allow attendees to explore some of the most challenging clinical situations in the management of hematologic malignancies. Many of which have have multiple potential approaches to care.


The case-based format of the Congress will challenge participants to apply new information they have learned, reflect on new practices they can bring back to their clinics to share with their peers, and ultimately improve patient outcomes in their practice settings.


Target Audience


This educational activity is directed toward community-based hematologists and medical oncologists, as well as fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of hematologic malignancies may also participate.


Learning Objectives


At the conclusion of this Congress, you should be better prepared to:


Detail methods by which clinical decision making in the management of hematologic malignancies can be personalized with the use of current and emerging biomarkers

Describe recent evidence on methods to optimize outcomes and consider them in the context of evolving treatment pathways and their application to individual patient cases

Explain practical methods to proactively mitigate and manage treatment-related toxicities so that optimized outcomes are not compromised in the management of hematologic malignancies

Evaluate new mechanistic approaches and compounds undergoing clinical investigation for the management of hematologic malignancies

State the therapeutic implications of recent evidence on evolving treatment paradigms for patients with hematologic tumors

Hot Topics for 2018:


Key biomarkers to consider in myeloma management

CAR-T cells and other immunotherapeutic strategies to treat hematologic malignancies

New clinical considerations for frontline and maintenance strategies for follicular lymphoma

New chronic lymphocytic leukemia agents: what patient and drug characteristics will inform sequencing decisions in relapsed/refractory disease

Novel therapies in acute leukemias and how they may alter treatment standards

Paradigm-changing strategies in the management of myeloproliferative neoplasms

Registration Needs updating Register Now
Currency:

USD

Registration Cost
Type
Early Registration

2017-09-21
Late Registration From: 2017-09-22 To: 0--
On site Registration
Physicians
299
399
0
Fellows
249
349
0
Nurses, PAs
249
349
0
Industry
699
799
0

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts

Accommodation
Accommodation:

The DIPLOMAT

3555 South Ocean Drive

Hollywood, FL 33019

Phone: 954-602-6000

Website: www.diplomatresort.com

Scientific Content Up to Date
Submission Info
Sponsors Exhibitors
General Info

Physicians' Education Resource, LLC

Phone: 609-378-3701

Fax: 609-257-0705

Email: info@gotoper.com

Contact
Organising Agency

Physicians' Education Resource, LLC

Phone: 609-378-3701

Fax: 609-257-0705

Email: info@gotoper.com

Event map
Revelant Events